Clinical Trials Logo
  1. Home
  2. Rectal Neoplasm
  3. NCT02630056

Validate the Dosimetric Parameters That Correlate With Acute Hematologic Toxicity (HT) in Patients With Rectal Cancer

Rectal Neoplasm Clinical Trial

Official title:
Validate the Dosimetric Parameters That Correlate With Acute Hematologic Toxicity (HT) in Patients With Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy

Clinical Trial Summary

The purpose of this study is to validate the dosimetric parameters that correlate with acute hematologic toxicity (HT) in patients with rectal cancer treated with neoadjuvant chemoradiotherapy.

Clinical Trial Description

The investigators' ongoing retrospective study investigated the clinical and dosimetric parameter (dosimetry of pelvic bone marrow) which relate with acute hematologic toxicity in patient with rectal cancer treated with neoadjuvant chemoradiotherapy. In order to validate the dosimetric limitation of pelvic bone marrow in decreasing the intensity of HT, the investigators want to conduct a study to observe the acute HT without assigning any specific interventions to the subjects of the study, who will receive the standard treatment according to the multidisciplinary team's (MDT) decision and patient choice. Therefore, this study's type is observational. ;

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02630056
Study type Observational
Source Sixth Affiliated Hospital, Sun Yat-sen University
Contact
Status Not yet recruiting
Phase N/A
Start date December 2015
Completion date December 2017
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT02586610 - Trial of Chemoradiation and Pembrolizumab in Patients With Rectal Cancer Phase 2
Completed NCT00549276 - Randomized Comparison of Curved Cutter Stapler and Linear Stapler N/A
Recruiting NCT01591798 - Efficacy Study of Robotic Surgery for Rectal Cancer Phase 2
Not yet recruiting NCT00819559 - Preoperative Chemoradiotheray for Rectal Cancer N/A
Recruiting NCT05984576 - Radiotherapy & Total Neoadjuvant Therapy for Recurrent Rectal Cancer in Previously Irradiated Patients, an Italian Association for Radiotherapy and Clinical Oncology (AIRO)-GI Platform: a Multi-centre Prospective Observational Study
Recruiting NCT02669992 - Loop Ileostomy Closure:Stapled or Hand-sewn Anastomoses? Suture or Mesh Closure of the Stoma Site? N/A
Completed NCT01910974 - Multicentric Study an Endoscopic Treatment of Digestive Neoplasia by Submucosal Dissection Evaluation of a New Water Jet System N/A
Active, not recruiting NCT00506623 - Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal Cancer Phase 2
Active, not recruiting NCT01766661 - Prospective Multicenter Randomized Controlled Trial On Two-Stage Turnbull-Cutait Coloanal Anastomosis For Rectal N/A
Terminated NCT00910494 - Intraoperative Radiotherapy for Rectal Cancer Using the Photon Radiosurgery System N/A